BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1602637)

  • 1. [Phase 3 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism--a multi-center trial].
    Torizuka K; Yonekura Y; Nishimura T; Ohtake T; Bunko H; Tamaki N; Uehara T
    Kaku Igaku; 1992 Apr; 29(4):413-33. PubMed ID: 1602637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase 2 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism].
    Torizuka K; Yonekura Y; Nishimura T; Tamaki N; Uehara T
    Kaku Igaku; 1992 Mar; 29(3):305-17. PubMed ID: 1583804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M; Kurihara T; Usami M; Honda M
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serial change of 123I-BMIPP SPECT imaging during recovery from stunned myocardium after acute myocardial infarction--correlation with 201Tl and two-dimensional echocardiography].
    Nakano A; Kondo M; Tokunaga S; Akiyama K; Mori Y; Nosue Y; Makita T; Tanio H; Shimono Y
    Kaku Igaku; 1995 Mar; 32(3):227-33. PubMed ID: 7739152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on myocardial imaging with beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid in patients with mitochondrial myopathy].
    Kihara K; Nakajo M; Shono H; Anan R; Otsuji Y; Nakao S; Nakabeppu Y; Nakagawa M; Kuriyama M; Fukunaga H
    Kaku Igaku; 1992 Apr; 29(4):453-61. PubMed ID: 1602640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of left ventricular functional recovery in patients with acute myocardial infarction using single photon emission computed tomography with thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid].
    Hashimoto A; Nakata T; Nagao K; Kobayashi H; Hase M; Yoshioka N; Tsuchihashi K; Yonekura S; Tanaka S; Iimura O
    J Cardiol; 1995 Aug; 26(2):59-68. PubMed ID: 7674145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous dual myocardial imaging with iodine-123-beta-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with coronary heart disease.
    Tawarahara K; Kurata C; Taguchi T; Aoshima S; Okayama K; Kobayashi A; Yamazaki N; Kaneko M
    Jpn Circ J; 1994 Feb; 58(2):107-15. PubMed ID: 8196152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: characteristics and prognostic implications].
    Narita M; Kurihara T
    J Cardiol; 1995 May; 25(5):223-31. PubMed ID: 7776191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I-beta-methyl-iodophenyl-pentadecanoic acid myocardial scintigraphy in diabetic patients without overt ischemic heart disease].
    Shinmura K; Tani M; Suganuma Y; Hasegawa H; Kawamura M; Nakamura Y; Hashimoto J; Kubo A
    J Cardiol; 1995 Jul; 26(1):23-32. PubMed ID: 7666341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic usefulness of myocardial SPECT with 123I-beta-methyl-iodophenyl pentadecanoic acid and 201Tl in unstable angina].
    Nakazawa Y; Tahara H; Suyama H; Kakio T; Ohue Y; Goto Y; Inoue K; Yamamoto Y; Nakamura N; Masui K
    Kaku Igaku; 1995 Sep; 32(9):953-8. PubMed ID: 8523843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of 201Tl/123I-BMIPP myocardial SPECT to evaluate myocardial viability and area at risk in acute myocardial infarction--comparison with 201Tl/99mTc-PYP dual SPECT].
    Isobe N; Toyama T; Hoshizaki H; Oshima S; Taniguchi K
    Kaku Igaku; 1997 Apr; 34(4):213-20. PubMed ID: 9183144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
    Nishimura T; Nagata S; Uehara T; Morozumi T; Ishida Y; Nakata T; Iimura O; Kurata C; Wakabayashi Y; Sugihara H; Otsuki K; Wada T; Koga Y
    Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic utility of myocardial imaging using 123I-labeled beta-methyl-iodophenyl pentadecanoic acid in ischemic heart disease].
    Uehara T; Nishimura T; Kumita S; Shimonagata T; Hayashida K; Oka H; Saito K; Nonogi H; Haze K
    Kaku Igaku; 1992 Mar; 29(3):347-58. PubMed ID: 1583807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.
    Yazaki Y; Isobe M; Takahashi W; Kitabayashi H; Nishiyama O; Sekiguchi M; Takemura T
    Heart; 1999 Feb; 81(2):153-9. PubMed ID: 9922350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
    Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
    Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
    Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
    Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
    Mori H; Sakamoto T; Ueda Y; Yano K
    J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of functional recovery and prognosis in patients with acute myocardial infarction by 123I-BMIPP and 201Tl myocardial single photon emission computed tomography: a multicenter trial.
    Nishimura T; Nishimura S; Kajiya T; Sugihara H; Kitahara K; Imai K; Muramatsu T; Takahashi N; Yoshida H; Osada T; Terada K; Ito T; Naruse H; Iwabuchi M
    Ann Nucl Med; 1998 Oct; 12(5):237-48. PubMed ID: 9839484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.